Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease.

Research output: Contribution to journalArticle

Abstract

We used a single adeno-associated viral (AAV) vector co-expressing tyrosine hydroxylase (TH) and GTP cyclohydrolase 1 (GCH1) to investigate the relationship between vector dose, and the magnitude and rate of recovery in hemi-parkinsonian rats. Intrastriatal injections of >1E10 genomic copies (gc) of TH-GCH1 vector resulted in complete recovery in drug-naïve behavior tests. Lower vector dose gave partial to no functional improvement. Stereological quantification revealed no striatal NeuN+ cell loss in any of the groups, whereas a TH-GCH1 dose of >1E11 gc resulted in cell loss in globus pallidus. Thus, a TH-GCH1 dose of 1E10 gc gave complete recovery without causing neuronal loss. Safety and efficacy was also studied in non-human primates where the control vector resulted in co-expression of the transgenes in caudate-putamen. In the TH-GCH1 group, GCH1 expression was robust but TH was not detectable. Moreover, TH-GCH1 treatment did not result in functional improvement in non-human primates.

Details

Authors
Organisations
Research areas and keywords

Subject classification (UKÄ) – MANDATORY

  • Neurosciences
Original languageEnglish
Article number2157
JournalScientific Reports
Volume3
Publication statusPublished - 2013
Publication categoryResearch
Peer-reviewedYes

Total downloads

No data available

Related research output

Cederfjäll, E., 2014, Brain Repair and Imaging in Neural Systems (BRAINS). 140 p.

Research output: ThesisDoctoral Thesis (compilation)

View all (1)